CitiusTech
unveils a pioneering Gen AI Quality & Trust solution for healthcare,
addressing reliability and credibility needs. Combining software framework with
consulting services, it offers automated measures and continuous monitoring.
New
Jersey: On
February 14th, 2024, CitiusTech, a prominent healthcare technology services
provider based in Princeton, N.J., unveiled a groundbreaking solution aimed at
addressing the critical requirements of reliability, quality, and trust in
Generative AI (Gen AI) applications within the healthcare sector.
The
newly introduced CitiusTech Gen AI Quality & Trust solution marks a
significant milestone in the industry, offering healthcare organizations a
comprehensive platform to ensure the integrity and credibility of their Gen AI
solutions. This solution encompasses the entire lifecycle of Gen AI
applications, from design and development to integration and monitoring,
empowering enterprises to embrace and expand the deployment of Gen AI
technologies with confidence.
Combining
sophisticated software architecture with tailored consulting, implementation,
and support services, the Gen AI Quality & Trust solution introduces a
state-of-the-art automated framework for decision-making and design. This
framework is equipped with pre-packaged measures, automated output validation
capabilities, and continuous monitoring mechanisms, ensuring the ongoing
quality and trustworthiness of Gen AI solutions.
Furthermore,
CitiusTech's solution seamlessly integrates with existing MLOps (Machine
Learning Operations), DataOps (Data Operations), and Quality Management
Solutions, providing a cohesive ecosystem for healthcare organizations to
manage their Gen AI initiatives effectively. Anchored in real-world healthcare
use cases and outcomes, the solution leverages a healthcare-specific repository
comprising over 70 metrics and 25 methods across seven dimensions: Accuracy,
Calibration, Robustness, Fairness, Bias, Toxicity, and Efficiency.
The
development of the Gen AI Quality & Trust solution has been shaped by
extensive beta-testing with multiple clients and healthcare innovators. Their
feedback and insights have played a crucial role in refining and enhancing this
pioneering offering, positioning CitiusTech at the forefront of driving
innovation and excellence in healthcare AI technology.
Rajan
Kohli, CEO, CitiusTech said,
“We are working with many clients on Gen AI solutions. But we find that over
80% of Gen AI proofs of concept and initiatives are delayed due to reliability
and compliance concerns, due to lack of trust in Gen AI solutions. This is the
pain point we are trying to solve for our customers, and the healthcare
industry at large. By prioritizing trust, quality, and reliability, we empower
our clients to fully embrace Gen AI technologies, gaining potential competitive
advantages in the healthcare sector. We are integrating this capability
seamlessly into all our solutions and projects, ensuring our clients can
confidently benefit from scaling Gen AI powered solutions.”
Sridhar
Turaga, SVP – Data and Analytics, CitiusTech said, “At present, there are no established
technology or platform agnostic solutions that measure quality and trust of
healthcare Gen AI solutions, end-to-end. Approaches used in building and
evaluating LLMs, and foundation models are useful, but have not been designed
for healthcare. Our Gen AI Quality & Trust Solution is the first systematic
approach in healthcare to quantitatively measure, verify and monitor Gen AI
solutions. This solution also synthesizes and builds on work by AI researchers,
platform players, industry forums and regulatory bodies. We go beyond pure math
or tech and contextualize everything to healthcare context.”
According
to TechSci Research,
the introduction of CitiusTech's Gen AI Quality & Trust solution is poised
to have a transformative impact on the healthcare market, addressing critical
challenges and unlocking significant opportunities for innovation and
improvement across various facets of healthcare delivery and operations. By
offering a comprehensive framework for ensuring the reliability, quality, and
trustworthiness of Generative AI (Gen AI) applications, CitiusTech's solution
can instill greater confidence among healthcare organizations in leveraging AI
technologies. This confidence is essential for widespread adoption and scaling
of AI applications, which have the potential to revolutionize patient care,
diagnosis, treatment, and operational efficiency within healthcare settings.
One
of the key benefits of the Gen AI Quality & Trust solution is its ability
to streamline the development and deployment of AI-powered solutions in
healthcare. By automating design, decision-making, and output validation
processes, CitiusTech's solution accelerates the implementation timeline for AI
projects, enabling organizations to realize the benefits of AI more rapidly and
efficiently. This accelerated pace of innovation can lead to improved patient
outcomes, reduced costs, and enhanced operational effectiveness for healthcare
providers.
Moreover,
the integration of CitiusTech's solution with existing MLOps, DataOps, and
Quality Management Solutions creates a seamless ecosystem for managing AI
initiatives within healthcare organizations. This integration not only enhances
operational efficiency but also ensures compliance with regulatory requirements
and industry standards, mitigating risks associated with AI deployment in
healthcare settings.
Additionally,
CitiusTech's healthcare-specific repository of metrics and methods across
various dimensions such as Accuracy, Fairness, and Efficiency provides
organizations with valuable insights and benchmarks for evaluating and
optimizing AI applications. This repository, coupled with feedback from
beta-testing with clients and healthcare innovators, enables continuous
improvement and refinement of AI solutions, driving greater effectiveness and
innovation in healthcare delivery.